Protective effects of hydroxytyrosol on contrast-induced nephropathy in rats

Protective effects of hydroxytyrosol on contrast-induced nephropathy in rats

Objective To explore the relationship between oxidative stress and contrast induced nephropathy（CIN）, and observe the effects of hydroxytyrosol on CIN in CIN rats.Methods84 Wistar rats were randomly divided into 3 groups: Sham-operation group, CIN model group and hydroxytyrosol intervention group. C...

Full description

Saved in:

Bibliographic Details
Main Authors:	PAN Pei-qiang, YU Fen-fen, SHAN Wen-hong, JI Wen-xuan, SUN Yan, LIU Gui-mei, HUANG Jun-yan
Format:	Article
Language:	zho
Published:	Editorial Department of Journal of Clinical Nephrology 2019-01-01
Series:	Linchuang shenzangbing zazhi
Subjects:	Contrast-induced nephropathy Oxidative stress Hydroxytyrosol
Online Access:	http://www.lcszb.com/thesisDetails?columnId=57908577&Fpath=home&index=0
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Effect of Astragalus injection on neutrophil gelatinase associated lipocalin level in patients with contrast-induced nephropathy
by: XIAO Yong-jia, et al.
Published: (2019-01-01)

Effective long-term hemofiltration in contrast-induced nephropathy
by: E. A. Tabakyan, et al.
Published: (2010-10-01)

Contrast induced nephropathy in women with infertility undergoing hysterosalpingography
by: Akin Usta, et al.
Published: (2024-12-01)

Risk factors of contrast-induced nephropathy after coronary angiography and the countermeasures
by: YANG Shu-mei, et al.
Published: (2016-01-01)

Personalized contrast agent dosing to prevent contrast induced nephropathy in high risk populations in Guangdong, China
by: Minqi Liao, et al.
Published: (2025-02-01)

Different routes of N-acetylcysteineon administration in preventing contrast-induced nephropathy in mild renal impairment patients undergoing contrast-enhanced CT
by: XU Xiao, et al.
Published: (2015-01-01)

Contrast-induced nephropathy - prevention and treatment
by: Mateusz Bajak, et al.
Published: (2024-11-01)

CONTRAST-INDUCED NEPHROPATHY IN CARDIOLOGY PRACTICE
by: O. I. Turenko, et al.
Published: (2011-06-01)

Hydroxytyrosol: A Promising Therapeutic Agent for Mitigating Inflammation and Apoptosis
by: Wafa Ali Batarfi, et al.
Published: (2024-11-01)

The prevention of sodium bicarbonate hydration therapy with contrast-induced nephropathy
by: TANG Na, et al.
Published: (2015-01-01)

Diagnostic value of serum Cystatin C for contrast-induced nephropathy:A Meta-analysis
by: WANG Yu-qin, et al.
Published: (2016-01-01)

Hydroxytyrosol protects isoproterenol-induced myocardial infarction through activating notch signaling
by: Elif Onat, et al.
Published: (2025-02-01)

Early-stage administration of hydroxytyrosol extends lifespan and delays aging in C. elegans
by: Nannan Du, et al.
Published: (2025-05-01)

Contrast-Induced Nephropathy: An Overview
by: Yuvashri Kaliyaperumal, et al.
Published: (2023-10-01)

Reduction in the risk of contrast-induced nephropathy using enhanced external counter-pulsation in patients with chronic kidney disease
by: Chun-Mei Zeng, et al.
Published: (2024-12-01)

Open-label pilot study using hydroxytyrosol as dietary supplements in patients with mitochondrial diseases
by: Tsz Sum Wong, et al.
Published: (2025-06-01)

Evaluating the role of trimetazidine in preventing myocardial injury and contrast-induced nephropathy in patients undergoing percutaneous coronary interventions
by: Anshul Jain, et al.
Published: (2025-05-01)

Meta-analysis of alprostadil E1 on prevention of contrast-induced nephropathy
by: JIAN Yong-hong, et al.
Published: (2015-01-01)

“CONTRAST” STUDY: COMPARİSİON OF NEPHROPROTECTİVE THREE PROTOCOLS: ACETYLCYSTEİNESODİUM BİCARBONATE-THEOPHYLLİNE, TO PREVENT CONTRAST-İNDUCED NEPHROPATHY
by: Ilker Murat Caglar, et al.
Published: (2014-01-01)

Effect and mechanism of berberine in alleviating contrast-induced nephropathy through regulating protein kinase B
by: Ran Yu, et al.
Published: (2024-10-01)

Hydroxytyrosol ameliorates imiquimod-induced psoriasis-like dermatitis by modulating ERK and NF-κB signaling pathways in mice
by: Meng Liu, et al.
Published: (2025-08-01)

Multienzyme cascade for synthesis of hydroxytyrosol via engineered Escherichia coli
by: Tianzhen Xiong, et al.
Published: (2025-01-01)

Application of disease prediction model in chronic kidney disease complicated with contrast induced nephropathy
by: ZHOU Min, et al.
Published: (2019-01-01)

CONTRAST-INDUCED NEPHROPATHY IN PATIENTS WITH STABLE CORONARY ARTERY DISEASE AND 1-YEAR PROGNOSIS
by: O. Iu. Mironov, et al.
Published: (2020-09-01)

Design, Synthesis, and Biological Evaluation of Novel Hydroxytyrosol Derivatives as Protectors for Vascular Endothelium Against Lipid Overload
by: Hou XX, et al.
Published: (2025-04-01)

Contrast-induced Nephropathy: Incidence and Reversibility in Patients Undergoing High-risk Percutaneous Coronary Intervention
by: Bharat Singh Sambyal, et al.
Published: (2025-01-01)

Synthesis and Health Effects of Phenolic Compounds: A Focus on Tyrosol, Hydroxytyrosol, and 3,4-Dihydroxyacetophenone
by: Wenyu Wang, et al.
Published: (2025-04-01)

Efficient Oxidative Polymerization of Hydroxytyrosol Using Horseradish Peroxidase Immobilized on a Magnetic Silica‐Coated Nanocatalyst
by: Fatih Sevim, et al.
Published: (2025-07-01)

The value of urinary cysteine rich protein 61 in early diagnosis of contrast-induced nephropathy
by: XIE Juan, et al.
Published: (2019-01-01)

Hydroxytyrosol induced ferroptosis through Nrf2 signaling pathway in colorectal cancer cells
by: Weipeng Li, et al.
Published: (2025-07-01)

Protective effect of hydroxytyrosol against hyperglycemia-induced phosphatidylserine exposure in human erythrocytes: focus on dysregulation of calcium homeostasis and redox balance
by: Rosaria Notariale, et al.
Published: (2025-09-01)

The Crucial Question About Contrast-Induced Nephropathy (CIN): Should It Affect Clinical Practice?
by: Damian Krzyżak, et al.
Published: (2025-03-01)

Collagen–Chitosan Composites Enhanced with Hydroxytyrosol for Prospective Wound Healing Uses
by: Miguel P. Batista, et al.
Published: (2025-05-01)

In Vitro Anti-Hepatitis B Virus Activity of Hydroxytyrosol from <i>Lindernia ruellioides</i>
by: Tong-Shi-Yao Zhao, et al.
Published: (2025-05-01)

Contrast-induced nephropathy in patients with acute coronary syndrome: clinical significance, diagnosis, prophylaxis
by: O. V. Demchuk, et al.
Published: (2020-04-01)

Protective effects of olive oil phenolics oleuropein and hydroxytyrosol against hydrogen peroxide-induced DNA damage in human peripheral lymphocytes
by: Zorić Nataša, et al.
Published: (2021-03-01)

Predictive ability of serum osmolarity for contrast-induced nephropathy after elective percutaneous coronary intervention: Are we having a new target?
by: Ahmad Samir, et al.
Published: (2025-02-01)

N-acetylcysteine in the Prevention of Contrast-induced Acute Kidney Injury: a Systematic Review and Meta-analysis of Randomized Controlled Clinical Trials
by: E. M. Mezhonov, et al.
Published: (2022-09-01)

Unveiling the Cardioprotective Potential of Hydroxytyrosol: Insights from an Acute Myocardial Infarction Model
by: Alejandra Bermúdez-Oria, et al.
Published: (2025-06-01)

Contrast-induced nephropathy after recanalization chronic coronary occlusion in patients with renal artery stenosis and normal creatinine levels
by: N. A. Yaitskiy, et al.
Published: (2023-10-01)